These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1475296)

  • 1. Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter.
    Rothman RB; Grieg N; Kim A; De Costa BR; Rice KC; Carroll FI; Pert A
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1135-42. PubMed ID: 1475296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine.
    Rothman RB; Mele A; Reid AA; Akunne HC; Greig N; Thurkauf A; de Costa BR; Rice KC; Pert A
    Pharmacol Biochem Behav; 1991 Oct; 40(2):387-97. PubMed ID: 1839568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.
    Villemagne VL; Rothman RB; Yokoi F; Rice KC; Matecka D; Dannals RF; Wong DF
    Synapse; 1999 Apr; 32(1):44-50. PubMed ID: 10188637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies of the structure-activity relationships of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine. Synthesis and evaluation of 1-(2-benzo[b]thienyl)-N,N-dialkylcyclohexylamines at dopamine uptake and phencyclidine binding sites.
    He X; Raymon LP; Mattson MV; Eldefrawi ME; de Costa BR
    J Med Chem; 1993 Dec; 36(25):4075-81. PubMed ID: 8258830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration.
    Claye LH; Akunne HC; Davis MD; DeMattos S; Soliman KF
    Mol Neurobiol; 1995; 11(1-3):55-66. PubMed ID: 8561968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and behavioral analysis of the effects of some bivalent ligand-based monoamine reuptake inhibitors.
    Tamiz AP; Bandyopadhyay BC; Zhang J; Flippen-Anderson JL; Zhang M; Wang CZ; Johnson KM; Tella S; Kozikowski AP
    J Med Chem; 2001 May; 44(10):1615-22. PubMed ID: 11334571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development.
    Rothman RB; Mele A; Reid AA; Akunne H; Greig N; Thurkauf A; Rice KC; Pert A
    FEBS Lett; 1989 Nov; 257(2):341-4. PubMed ID: 2583282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologues at dopamine-uptake and phencyclidine- and sigma-binding sites.
    He XS; Raymon LP; Mattson MV; Eldefrawi ME; de Costa BR
    J Med Chem; 1993 Apr; 36(9):1188-93. PubMed ID: 8098066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain.
    Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N; Nakanishi S
    Brain Res; 1999 Dec; 849(1-2):85-96. PubMed ID: 10592290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine.
    Tella SR; Ladenheim B; Cadet JL
    J Pharmacol Exp Ther; 1997 Apr; 281(1):508-13. PubMed ID: 9103538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
    Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB
    Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-[1-(2-Benzo[b]thiopheneyl)cyclohexyl]piperidine hydrochloride (BTCP) yields two active primary metabolites in vivo. Identification and quantification of BTCP primary metabolites in mice plasma, urine, and brain and their affinity for the neuronal dopamine transporter.
    Deleuze-Masquefa C; Michaud-Dutreilh M; Vignon J; Kamenka JM
    Eur J Pharm Sci; 2000 Feb; 9(4):345-54. PubMed ID: 10664474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.
    Froimowitz M; Wu KM; Moussa A; Haidar RM; Jurayj J; George C; Gardner EL
    J Med Chem; 2000 Dec; 43(26):4981-92. PubMed ID: 11150168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
    Xu C; Coffey LL; Reith ME
    Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domains.
    Dersch CM; Akunne HC; Partilla JS; Char GU; de Costa BR; Rice KC; Carroll FI; Rothman RB
    Neurochem Res; 1994 Feb; 19(2):201-8. PubMed ID: 8183430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of dopamine transporter and locomotor effects of cocaine, GBR 12909, epidepride, and SCH 23390 in C57BL and DBA mice.
    Womer DE; Jones BC; Erwin VG
    Pharmacol Biochem Behav; 1994 Jun; 48(2):327-35. PubMed ID: 8090798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel in vivo electrophysiological assay for the effects of cocaine and putative "cocaine antagonists" on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neurons.
    Hinerth MA; Collins HA; Baniecki M; Hanson RN; Waszczak BL
    Synapse; 2000 Dec; 38(3):305-12. PubMed ID: 11020233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation by dopamine of [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP, a phencyclidine derivative) binding to the dopamine uptake complex.
    Maurice T; Barbanel G; Kamenka JM; Vignon J
    Neuropharmacology; 1991 Jun; 30(6):591-8. PubMed ID: 1681444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo.
    Tolliver BK; Newman AH; Katz JL; Ho LB; Fox LM; Hsu K; Berger SP
    J Pharmacol Exp Ther; 1999 Apr; 289(1):110-22. PubMed ID: 10086994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters.
    Dutta AK; Fei XS; Beardsley PM; Newman JL; Reith ME
    J Med Chem; 2001 Mar; 44(6):937-48. PubMed ID: 11300876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.